Pharmamar
Clinical trials sponsored by Pharmamar, explained in plain language.
-
New drug PM14 tested in patients with advanced cancers
Disease control CompletedThis early-stage trial tested a new drug called PM14 in 126 people with advanced solid tumors that had not responded to standard treatments. The main goals were to find the safest dose and to see if the drug could shrink tumors. The study is now complete, and results will help gu…
Phase: PHASE1 • Sponsor: PharmaMar • Aim: Disease control
Last updated May 17, 2026 05:45 UTC
-
Small study tests drug interaction in advanced cancer patients
Knowledge-focused CompletedThis study looked at how bosentan, a drug that affects liver enzymes, changes the way the body processes the cancer drug lurbinectedin. It involved 11 adults with advanced solid tumors who had no other treatment options. The goal was to measure drug levels in the blood to underst…
Phase: PHASE1 • Sponsor: PharmaMar • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Drug interaction study reveals how itraconazole alters lurbinectedin levels
Knowledge-focused CompletedThis study looked at how the antifungal drug itraconazole changes the way the body processes the cancer drug lurbinectedin. Fourteen adults with advanced solid tumors that had no standard treatment took part. The goal was to measure drug levels in the blood to understand the inte…
Phase: PHASE1 • Sponsor: PharmaMar • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC